Vanda Pharmaceuticals Inc VNDA:NASDAQ

Last Price$10.01NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/13/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$8.08 (1)
Ask (Size)$13.00 (1)
Day Low / HighN/A - N/A
Volume790.5 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 05/13/2022


Vanda Pharmaceuticals Inc ( NASDAQ )

Price: $10.01
Change: +0.26 (2.67%)
Volume: 790.5 K
4:00PM ET 5/13/2022

Kiniksa Pharmaceuticals Ltd ( NASDAQ )

Price: $8.22
Change: +0.23 (2.88%)
Volume: 341.5 K
4:00PM ET 5/13/2022

Eagle Pharmaceuticals Inc ( NASDAQ )

Price: $44.00
Change: -0.20 (0.45%)
Volume: 124.5 K
4:00PM ET 5/13/2022

Albireo Pharma Inc ( NASDAQ )

Price: $28.00
Change: -0.11 (0.39%)
Volume: 255.7 K
4:00PM ET 5/13/2022

SIGA Technologies Inc ( NASDAQ )

Price: $7.46
Change: +0.04 (0.54%)
Volume: 855.00
4:00PM ET 5/13/2022

Read more news Recent News

-- Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $60.2M, vs. Street Est of $58M
4:11PM ET 5/05/2022 MT Newswires


--Jefferies Downgrades Vanda Pharmaceuticals to Hold From Buy, Adjusts Price Target to $12 From $24
5:27AM ET 2/25/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q4 Revenue $68M, vs. Street Est of $70M
4:10PM ET 2/23/2022 MT Newswires


Sector Update: Health Care Stocks Mixed in Late Trade
4:01PM ET 2/04/2022 MT Newswires

Health care stocks were drifting between small gains and losses, with the NYSE Health Care Index rising 0.2% this afternoon and the SPDR Health Care Select...

Company Profile

Business DescriptionVanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC. View company web site for more details
Address2200 Pennsylvania Avenue NW
Washington, District of Columbia 20037
Number of Employees270
Recent SEC Filing05/06/202210-Q
Chairman, President & Chief Executive OfficerMihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer & VPKevin Moran
Secretary, Senior VP & General CounselTim Williams
Senior Vice President & Chief Marketing OfficerKim Wijkstrom

Company Highlights

Price Open$9.88
Previous Close$10.01
52 Week Range$9.24 - 21.86
Market Capitalization$565.5 M
Shares Outstanding56.5 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement07/27/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings31.28
Earnings per Share$0.31
Beta vs. S&P 500N/A
Revenue$193.1 M
Net Profit Margin6.79%
Return on Equity3.65%

Analyst Ratings as of 03/22/2022

Consensus RecommendationConsensus Icon
Powered by Factset